|
Volumn 34, Issue 8, 2002, Pages 3378-3383
|
Autologous hematopoietic stem cell transplantation for high-risk Hodgkin's disease: A single-center experience with the first 100 patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLEOMYCIN;
CHLORMETHINE;
CYCLOPHOSPHAMIDE;
DACARBAZINE;
DOXORUBICIN;
EPIRUBICIN;
ETOPOSIDE;
IFOSFAMIDE;
MELPHALAN;
PREDNISONE;
PROCARBAZINE;
VINBLASTINE;
VINCRISTINE;
ADULT;
ARTICLE;
AUTOTRANSPLANTATION;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
CONTROLLED STUDY;
DRUG MEGADOSE;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HODGKIN DISEASE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RISK FACTOR;
SURGICAL TECHNIQUE;
SURVIVAL TIME;
TOXICITY;
ADOLESCENT;
BLOOD CELL COUNT;
DISEASE FREE SURVIVAL;
METHODOLOGY;
MIDDLE AGED;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
RECURRENT DISEASE;
RETROSPECTIVE STUDY;
STEM CELL MOBILIZATION;
STEM CELL TRANSPLANTATION;
SURVIVAL;
TIME;
ADOLESCENT;
ADULT;
BLOOD CELL COUNT;
COMBINED MODALITY THERAPY;
DISEASE-FREE SURVIVAL;
FEMALE;
HEMATOPOIETIC STEM CELL MOBILIZATION;
HODGKIN DISEASE;
HUMANS;
MALE;
MIDDLE AGED;
RECURRENCE;
RETROSPECTIVE STUDIES;
STEM CELL TRANSPLANTATION;
SURVIVAL ANALYSIS;
TIME FACTORS;
TRANSPLANTATION, AUTOLOGOUS;
|
EID: 0036905024
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)03690-4 Document Type: Article |
Times cited : (9)
|
References (28)
|